Comparison

Enfortumab vedotin-ejfv (ADC)

Item no. ANSY-DHJ41099-5mg
Manufacturer Antibody System
Amount 5 mg
Quantity options 5 mg
Category
Type Antibody Monoclonal
Clone Enfortumab vedotin-ejfv
Specific against Human (Homo sapiens)
Purity >90% as determined by SEC.
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Alias Padcev,ASG-22ME
Available
Manufacturer - Type
Primary
Manufacturer - Applications
Research Grade Biosimilar
Manufacturer - Targets
LNIR, NECTIN4, PRR4 receptor-related protein 4, Nectin cell adhesion molecule 4, Ig superfamily receptor LNIR, Nectin-4, PVRL4
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Product description
Enfortumab vedotin-ejfv is an ADC consisting of a Nectin-4-directed antibody and Monomethyl auristatin E (MMAE) , suitable for adult patients with locally advanced or metastatic urothelial carcinoma, or who have received programmed cell death protein 1 (PD-1) inhibitor or programmed cell death ligand 1 (PD-L1) inhibitor therapy or neoadjuvant/adjuvant platinum-based chemotherapy for locally advanced or metastatic cancer.
Purification
Purified by Ion Exchange Chromatography.
Note
For research use only. Not suitable for clinical or therapeutic use.
Clonality
Monoclonal
Concentration
1 mg/ml
Recombinant
Yes

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close